Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 51655-115

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 51655-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 115 25)

Label for buPROPion HCl Extended-Release Tablets, USP (SR) 150 mg, containing 60 tablets. The label indicates prescription use only with storage instructions at 20°-25°C (68°-77°F). It provides warnings about the use with other bupropion-containing medicines. The product is repackaged by Northwind Pharmaceuticals, LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of bupropion hydrochloride, showing a chlorophenyl ring attached to a ketone and a tert-butylamino group, with the hydrochloride salt indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.